
CareTrust REIT (CTRE) Stock Forecast & Price Target
CareTrust REIT (CTRE) Analyst Ratings
Bulls say
CareTrust REIT has substantially expanded its structured finance portfolio from $15 million to $871 million since early 2022, enhancing its operator relationships and diversifying yield. The company benefits from a favorable supply/demand disconnect in the healthcare real estate market, evidenced by a robust 22% same-store NOI growth among similarly positioned REITs over the past two years, with expectations for continued growth over the next five years. CareTrust's portfolio optimization efforts and management's improved capacity to deploy capital efficiently position the company favorably as tenant credit concerns have stabilized.
Bears say
CareTrust REIT's outlook is negatively affected by a lowered growth forecast, which is projected to lead to a decline in cash collections by approximately 5% and a slowdown in investment activity to around $1.0 billion. Increasing competition in the real estate market may drive property prices higher, potentially squeezing profitability and creating challenges for rent collection, especially in light of regulatory pressures such as the CA 525 bill that could impact tenant operators in California. Furthermore, the potential for new tenant issues and deteriorating conditions in capital markets may exacerbate liquidity problems, negatively influencing both cash investments and overall valuation in the healthcare real estate sector.
This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.
CareTrust REIT (CTRE) Analyst Forecast & Price Prediction
Start investing in CareTrust REIT (CTRE)
Order type
Buy in
Order amount
Est. shares
0 shares